An abnormality in the c-sis protooncogene was identified in leukocyte DNA from members of a family predisposed to the development of meningioma, and was found to be associated with the development of the tumor in those individuals. Molecular analysis of this abnormality demonstrated a deletion within the fifth intron of the c-sis gene. The normal c-sis gene has an Alu sequence in this region which includes two perfect 130 nucleotide repeated sequences separated by 5 bp. The deleted c-sis allele is missing precisely one copy of the 130 bp repeat and the intervening 5 bp. An identical deletion was also found in DNA from 1 of 13 sporadic meningiomas. (J. Clin.
Introduction
The c-sis protooncogene is located on human chromosome 22 (1) . It encodes one of two polypeptides comprising platelet-derived growth factor (2) . The c-sis gene is expressed in endothelial cells (3) , activated monocytes (4) , smooth muscle cells lining developing vasculature (5) , astrocytes in the developing central nervous system (6) , and tumors of fibroblastoid or glial origin (7) . Transduction of this gene to produce the simian sarcoma virus conferred transforming properties on this retrovirus (8) . This virus is capable of causing sarcomas and meningiomas in monkeys (9) .
Human meningiomas have been associated frequently with complete or partial deletions of chromosome 22 (10) . Homozygosity or hemizygosity of genes on chromosome 22 are found in 43% of meningiomas (1 1) . Abnormalities in the region of the c-sis gene are found more frequently than those of other loci on this chromosome.
Individuals within a family predisposed to the development of meningioma have been described (12) . An abnormality of the c-sis gene was closely associated with the development of the tumor. To elucidate the molecular basis of meningioma development in these individuals, we have cloned, mapped, and sequenced the abnormal c-sis allele from one such individual.
Methods
DNA sources. DNA from members of this family and a normal blood donor (L.R.) were obtained from fresh leukocytes or Epstein-Barr virus immortalized lymphocytes. DNA was extracted (13) from sporadic meningiomas, the H9 human lymphoid cell line, the HOS human osteogenic sarcoma cell line, the A 172 human glioblastoma cell line, and the SKES human sarcoma cell line using autoclaved reagents and utensils. Phage clone lambda SIS-A (14) includes exons 1-4 of the normal human c-sis gene (Fig. 3) . Plasmid clones pL33-M, pL33-5, and pB3L include three contiguous Bam HI fragments from the normal human c-sis gene (2), whereas plasmid cDNA clone pSM-I is from a human T-lymphotropic virus type 1 immortalized cell line (15) (Fig. 3 ).
Cloning and sequence analysis. A genomic library was prepared according to published procedures (13) using lambda EMBL3 (Promega Biotech., Madison, WI) and Mbo I partially digested DNA from lymphocyte DNA ofpatient 11.8 ( Fig. 1) . The library was screened with the 1.8-kb Bam HI fragment of pL33-5 ( Fig. 3) , and six positive clones were obtained. The 3.8-kb Sac I fragment from one ofthese clones was subcloned into lambda ZAP (Stratagene Inc., La Jolla, CA) and excised according to the manufacturer's protocol in a Bluescript vector, designated pMD. A portion of pL33-M and pMD were sequenced on both strands using plasmid DNA by the partial chemical cleavage method (16; nucleotides 50-250 and 580-880; Fig. 4 ) and the dideoxynucleotide chain termination method (17; nucleotides 1-1200; Fig. 4 (Fig. 4) , and the L33-5 DNA fragment used as a hybridization probe (Fig.  ] 2, a and d). The hybridizing DNA fragments from the nondeleted allele are indicated in kilobases after digestions with Pst I (Fig. 2, a and d ), Bgl II (Fig. 2 b) , or Sac I (Fig. 2 c) . Abbreviations: B, Bam HI; G, Bgl II; H, Sph I; P, PstI;S, Sac I; V, PvuII;X, XbaI.
ucts hybridizing with the pL33-5 probe were identical with DNAs from affected and unaffected individuals (not shown). Thus, the structural abnormality in the c-sis gene can be attributed to a deletion of -0.1 kb within the fifth intron of the c-sis gene (Fig. 3) .
Isolation and characterization of the deleted c-sis allele. Nucleotide sequence analysis of the normal and deleted c-sis alleles. A 1,200-bp region of intron 5 from pL33-M and pMD was sequenced (Fig. 4) . pL33-M contains an Alu sequence between nucleotides 405 and 821. This Alu sequence is unusual in that it has two copies of the monomer 1 sequence, one having 5 and the other 16 nucleotide differences among the 1 33-bp of the consensus sequence described by Kariya and colleagues (19) . These are followed immediately by a sequence with 17 differences among 149 bp of the consensus monomer 2 sequence. An adenylate-rich 1 3-bp sequence follows the Alu sequence. The Alu sequence is also flanked by imperfect repeats of a 15-bp sequence with one difference from the consensus sequence. Within the Alu sequence are two copies of a perfect 1 30-bp repeat separated by five nucleotides.
The sequence from pMD is identical to that from pL33-M except for a 135-bp deletion which includes one copy of the 130-bp repeat and the five nucleotides between the direct repeats found in the normal allele (Fig. 4) .
Polymerase chain amplification analysis ofthe c-sis gene in members ofthefamily predisposed to meningiomas and individuals with sporadic meningiomas. A polymerase chain amplification assay was developed using primers which flanked the Alu repeat sequences. A 2.1-kb PCR product was identified using the cloned allele, pMD, whereas a 2.2-kb PCR product was noted with DNA from the H9 lymphoid cell lines (Fig. 5  a) . Only a 2.2-kb product was found after PCR with leukocyte DNA from family members (111. 13, III. 12, 111.1 1, and 11.7) and individual 11.9 who lacked the c-sis abnormality, while 2.1-and 2.2-kb PCR products were found with DNA from family members (111.21, 11.8, and 11.2) with the c-sis abnormality. 
AArCCCAGCrACrnGGGPGGCAGCbGPGAGAATCACI'GAACC1OGAGJGGTG3GTMCPrGMA TO3CZC(J CrGCACrCCAACCIGGGC 800
PVu II PGGAAACCrCAAPGrGCAPCrAAGAAAMATAG AAAAAP=GrOTPGCAGCICCATGGCIGACCAClICATACrlAG(l.r PTAl 1200 The PCR assay was also utilized to screen DNA samples from brain tumor samples derived from unrelated individuals. All of the five nonmeningioma samples (2, 4, 8, 9 , and 13) produced only a 2.2-kb PCR product, while one (sample 1) of the eight meningioma tissues (samples 1, 3, 5, 6, 7, 11, 12, and 14) produced PCR products of 2.1 and 2.2 kb (Fig. 5 b) .
To assess the structural abnormality in meningioma No. 1, Southern blot hybridization was performed after Pst I digestion of fresh tissue (Fig. 2 d) . The presence of 3.4-and 3.3-kb bands demonstrates a polymorphism in this sample similar to that found in the members of the family predisposed to the development of meningioma. In contrast, Pst I digestion of DNAs from five other meningiomas (samples 6 and 16-19) reveal only the 3.4-kb band.
Differences in the relative intensities of bands from deleted and nondeleted alleles between the PCR and Southern blot analyses for patients 11. The structural alteration of the c-sis gene noted in leukocyte DNA, from both of the family members with meningioma who were available for analysis and the one additional family member without meningioma (12), was not found in six additional family members or 25 unrelated and unaffected individuals ( Fig. 1; data (Fig. 2) . Thus, the abnormality in the c-sis gene represents a deletion rather than a novel Pst I site.
The location of the deletion within an intron (Fig. 3 ) and an Alu sequence (Fig. 4) contributes to a growing number of observations that these sequences are not without some function (27, 28) . For example, the presence of a 15-nucleotide flanking sequence suggests that Alu sequences may be involved in transposition. Alternatively, the deletion of precisely one copy of the 130-bp repeat sequence and the intervening 5-bp sequence (Fig. 4) suggests that this deletion arose by homologous recombination between identical sequences.
Is the c-sis deletion associated with meningioma development? The finding of an identical deletion in both the familial cases and a sporadic case of meningioma suggests an association exists. Numerous samples from other meningioma patients and unaffected individuals are being examined to assess whether there is a statistically significant association of this genetic abnormality with sporadic meningiomas. Additional information about the role ofthis gene in oncogenesis depends on analysis of c-sis genetic alterations in individuals with other central nervous systems tumors, or individuals with conditions such as neurofibromatosis which predispose to meningiomas and other central nervous system tumors.
How might the c-sis deletion be related to meningioma development? One hypothesis is that a recessive oncogene, either c-sis or a gene in close proximity to c-sis on chromosome 22, may be involved in meningioma development. If c-sis has this activity, the deletion in the fifth intron may inactivate one allele, and the other allele may be inactivated in the tumor. This would be analogous to the function of suppressor genes involved in the development ofretinoblastoma, osteosarcoma, and Wilm's tumor (29, 30 ). An alternate explanation is that the deletion in the fifth intron activates the expression of the c-sis gene. A point mutation in the fourth intron of c-Ha-ras is also associated with overexpression (27) . Since some Alu sequences act as RNA polymerase III promoters (28) , this activity may disrupt expression of the c-sis gene. Analysis of c-sis expression from the deleted allele and normal alleles is in progress to test these hypotheses.
